| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 132, 2017-2023, Copyright © 1993 by Endocrine Society
ARTICLES |
VN Sumantran and EL Feldman
Department of Neurology, University of Michigan, Ann Arbor 48109.
In the human neuroblastoma cell line SH-SY5Y, insulin-like growth factors I (IGF-I) and II (IGF-II) are established mitogens, and IGF-I appears to promote SH-SY5Y neuronal differentiation. Studies show that c-myc gene product is a transcription factor associated with cell proliferation, and that c-myc messenger RNA levels decrease in differentiating SH-SY5Y neurons. Using Northern analysis we show that 24 h exposure of SH-SY5Y cells to IGF-I (3-10 nM) causes a 3- to 5-fold decrease in c-myc expression. The decrease in c-myc expression due to IGF-I is mediated via the type I IGF receptor and coincides with an IGF- I-mediated induction of the neuronal differentiation markers growth cone associated protein 43 and tissue type plasminogen activator. Under these conditions, IGF-I (10 nM) did not markedly affect the levels of Max messenger RNA expression. Thus, the differentiation promoting activity of IGF-I in SH-SY5Y cells in part due to IGF-I-dependent regulation of the expression of genes involved in neuronal differentiation.
This article has been cited by other articles:
![]() |
P. J. Jenkins and M. Besser CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2935 - 2941. [Full Text] [PDF] |
||||
![]() |
H.-L. Cheng, M. Shy, and E. L. Feldman Regulation of Insulin-Like Growth Factor-Binding Protein-5 Expression during Schwann Cell Differentiation Endocrinology, October 1, 1999; 140(10): 4478 - 4485. [Abstract] [Full Text] |
||||
![]() |
D. Chambery, S. Mohseni-Zadeh, B. d. Galle, and S. Babajko N-myc Regulation of Type I Insulin-like Growth Factor Receptor in a Human Neuroblastoma Cell Line Cancer Res., June 1, 1999; 59(12): 2898 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kim, P. S. Leventhal, A. R. Saltiel, and E. L. Feldman Insulin-like Growth Factor-I-mediated Neurite Outgrowth in Vitro Requires Mitogen-activated Protein Kinase Activation J. Biol. Chem., August 22, 1997; 272(34): 21268 - 21273. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Leventhal, E. A. Shelden, B. Kim, and E. L. Feldman Tyrosine Phosphorylation of Paxillin and Focal Adhesion Kinase during Insulin-like Growth Factor-I-stimulated Lamellipodial Advance J. Biol. Chem., February 21, 1997; 272(8): 5214 - 5218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Menouny, M. Binoux, and S. Babajko Role of Insulin-Like Growth Factor Binding Protein-2 and Its Limited Proteolysis in Neuroblastoma Cell Proliferation: Modulation by Transforming Growth Factor-{beta} and Retinoic Acid Endocrinology, February 1, 1997; 138(2): 683 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Singleton, V. M. Dixit, and E. L. Feldman Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins J. Biol. Chem., December 13, 1996; 271(50): 31791 - 31794. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |